Home › Funds › Banque Cantonale Vaudoise › BSX
Banque Cantonale Vaudoise position in BSX
BOSTON SCIENTIFIC CORP · Health Care
Banque Cantonale Vaudoise reported holding 67,611 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$2.89B, representing 0.40% of its reported portfolio and ranking #44 among its reported holdings. Banque Cantonale Vaudoise has disclosed BSX holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Banque Cantonale Vaudoise's BSX position evolved
Banque Cantonale Vaudoise first disclosed a stake in BSX in Q3 2023 at 49,427 shares (US$2.6M). The position peaked in Q2 2026 at 67,611 shares, worth US$2.89B. Across 10 filings, Banque Cantonale Vaudoise increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 67,611 shares valued at US$2.89B — an increase of 1,288 shares quarter over quarter.. Notable position changes include a 48% trim in Q4 2023 (shares rose 18% over the following quarter), a 62% increase in Q2 2025 (shares fell 9% over the following quarter), a 61% increase in Q1 2026 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 49.43K | $2.61M | New |
| Q4 2023 | 25.68K | $1.48M | Reduce |
| Q1 2024 | 26.57K | $1.82M | Add |
| Q3 2024 | 31.40K | $2.63M | Add |
| Q1 2025 | 32.01K | $3.23M | Add |
| Q2 2025 | 51.84K | $5.57M | Add |
| Q3 2025 | 44.61K | $4.36M | Reduce |
| Q4 2025 | 41.22K | $3.93M | Reduce |
| Q1 2026 | 66.32K | $4.16M | Add |
| Q2 2026 | 67.61K | $2.89B | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 19 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B), Janus Henderson Group (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- PRIMECAP MANAGEMENT CO/CA/ 50.52M sh · $2.16B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
- Bollard Group LLC 18.42M sh · $786.20M · Q2 2026
More on Banque Cantonale Vaudoise
FAQ
How long has Banque Cantonale Vaudoise held BSX?
Banque Cantonale Vaudoise has disclosed BSX holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is Banque Cantonale Vaudoise's current position in BSX?
As of Q2 2026, Banque Cantonale Vaudoise holds 67.61K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $2.89B, representing 0.40% of its reported portfolio and ranking #44.
Has Banque Cantonale Vaudoise been buying or selling BSX?
In the latest 13F filing (Q2 2026), Banque Cantonale Vaudoise increased its position in BSX. The position peaked in Q2 2026 at 67.61K shares.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, Janus Henderson Group, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.